GSA Capital Partners’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-19,460
| Closed | -$1.32M | – | 1882 |
|
|
2019
Q3 | $1.32M | Sell |
19,460
-31,975
| -62% | -$2.2M | 0.18% | 78 |
|
|
2019
Q2 | $2.99M | Sell |
51,435
-2,430
| -5% | -$144K | 0.34% | 14 |
|
|
2019
Q1 | $3.77M | Buy |
53,865
+5,565
| +12% | +$413K | 0.38% | 11 |
|
|
2018
Q4 | $3.11M | Sell |
48,300
-30,900
| -39% | -$2.17M | 0.36% | 28 |
|
|
2018
Q3 | $5.56M | Sell |
79,200
-16,700
| -17% | -$977K | 0.31% | 10 |
|
|
2018
Q2 | $4.83M | Buy |
95,900
+51,600
| +116% | +$2.05M | 0.24% | 31 |
|
|
2018
Q1 | $1.39M | Buy |
44,300
+23,000
| +108% | +$763K | 0.07% | 464 |
|
|
2017
Q4 | $728K | Sell |
21,300
-41,800
| -66% | -$1.33M | 0.04% | 753 |
|
|
2017
Q3 | $2.02M | Buy |
63,100
+19,200
| +44% | +$606K | 0.14% | 149 |
|
|
2017
Q2 | $1.43M | Buy |
43,900
+28,800
| +191% | +$912K | 0.09% | 302 |
|
|
2017
Q1 | $475K | Sell |
15,100
-16,100
| -52% | -$476K | 0.03% | 1127 |
|
|
2016
Q4 | $917K | Sell |
31,200
-25,813
| -45% | -$787K | 0.05% | 604 |
|
|
2016
Q3 | $1.65M | Buy |
57,013
+12,645
| +29% | +$352K | 0.09% | 323 |
|
|
2016
Q2 | $1.15M | Sell |
44,368
-61,783
| -58% | -$1.64M | 0.06% | 544 |
|
|
2016
Q1 | $2.63M | Sell |
106,151
-6,109
| -5% | -$168K | 0.17% | 95 |
|
|
2015
Q4 | $3.95M | Buy |
112,260
+7,512
| +7% | +$201K | 0.19% | 63 |
|
|
2015
Q3 | $2.22M | Sell |
104,748
-38,802
| -27% | -$1,000K | 0.11% | 220 |
|
|
2015
Q2 | $3.99M | Buy |
143,550
+40,533
| +39% | +$1.14M | 0.15% | 87 |
|
|
2015
Q1 | $3.15M | Buy |
103,017
+38,800
| +60% | +$1.23M | 0.13% | 140 |
|
|
2014
Q4 | $2.05M | Buy |
64,217
+21,485
| +50% | +$699K | 0.14% | 143 |
|
|
2014
Q3 | $1.21M | Buy |
42,732
+13,500
| +46% | +$376K | 0.06% | 380 |
|
|
2014
Q2 | $801K | Buy |
29,232
+10,803
| +59% | +$288K | 0.04% | 819 |
|
|
2014
Q1 | $485K | Sell |
18,429
-19,393
| -51% | -$556K | 0.03% | 802 |
|
|
2013
Q4 | $1.11M | Buy |
37,822
+1,490
| +4% | +$47.3K | 0.09% | 303 |
|
|
2013
Q3 | $1.11M | Buy |
36,332
+4,900
| +16% | +$164K | 0.09% | 300 |
|
|
2013
Q2 | $997K | Buy |
+31,432
| New | +$1.03M | 0.12% | 218 |
|
GSA Capital Partners's GHDX Position: Q4 2019 in Review
GSA Capital Partners sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 19,460 shares — an estimated $1.32M sold.
GSA Capital Partners first reported a position in GHDX in Q2 2013 and held it in 26 quarters. The position peaked at $5.56M in Q3 2018. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.
- GSA Capital Partners reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
- GSA Capital Partners sold 19,460 Genomic Health, Inc. shares in Q4 2019, an estimated $1.32M.
- GSA Capital Partners first reported a position in Genomic Health, Inc. in Q2 2013 and held it in 26 quarters.
- GSA Capital Partners's Genomic Health, Inc. position peaked at $5.56M in Q3 2018.
- 0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.
Based on GSA Capital Partners's 13F filing for Q4 2019, filed 12 Feb 2020.